<VariationArchive VariationID="599040" VariationName="NM_003221.4(TFAP2B):c.650del (p.Gly217fs)" VariationType="Deletion" Accession="VCV000599040" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2018-12-24" MostRecentSubmission="2018-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="590168" VariationID="599040">
      <GeneList>
        <Gene Symbol="TFAP2B" FullName="transcription factor AP-2 beta" GeneID="7021" HGNC_ID="HGNC:11743" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="50818355" stop="50847619" display_start="50818355" display_stop="50847619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="50786438" stop="50815325" display_start="50786438" display_stop="50815325" Strand="+" />
          </Location>
          <OMIM>601601</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TFAP2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TFAP2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003221.4(TFAP2B):c.650del (p.Gly217fs)</Name>
      <CanonicalSPDI>NC_000006.12:50836107:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="50836108" stop="50836108" display_start="50836108" display_stop="50836108" variantLength="1" positionVCF="50836107" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="50803821" stop="50803821" display_start="50803821" display_stop="50803821" variantLength="1" positionVCF="50803820" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G217fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.50803822del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.50803822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.50836109del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.50836109del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008438.1" sequenceAccession="NG_008438" sequenceVersion="1" change="g.22384del">
            <Expression>NG_008438.1:g.22384del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003221.4" sequenceAccession="NM_003221" sequenceVersion="4" change="c.650del" MANESelect="true">
            <Expression>NM_003221.4:c.650del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003212.2" sequenceAccession="NP_003212" sequenceVersion="2" change="p.Gly217fs">
            <Expression>NP_003212.2:p.Gly217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1561964103" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein truncation">
        <XRef ID="0015" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003221.4(TFAP2B):c.650del (p.Gly217fs) AND Char syndrome" Accession="RCV000735439" Version="2">
        <ClassifiedConditionList TraitSetID="2186">
          <ClassifiedCondition DB="MedGen" ID="C1868570">Char syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-11-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-12-24" MostRecentSubmission="2018-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2186" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="775" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Patent ductus arteriosus with facial dysmorphism and abnormal fifth digits</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Char syndrome</ElementValue>
                <XRef ID="MONDO:0008209" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHAR</ElementValue>
                <XRef Type="MIM" ID="169100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Char syndrome is characterized by the triad of typical facial features, patent ductus arteriosus, and aplasia or hypoplasia of the middle phalanges of the fifth fingers. Typical facial features are depressed nasal bridge and broad flat nasal tip, widely spaced eyes, downslanted palpebral fissures, mild ptosis, short philtrum with prominent philtral ridges with an upward pointing vermilion border resulting in a triangular mouth, and thickened (patulous) everted lips. Less common findings include other types of congenital heart defects, other hand and foot anomalies, hypodontia, hearing loss, myopia and/or strabismus, polythelia, parasomnia, craniosynostosis (involving either the metopic or sagittal suture), and short stature.</Attribute>
                <XRef ID="NBK1106" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1237" />
                <XRef ID="1237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301285</ID>
                <ID Source="BookShelf">NBK1106</ID>
              </Citation>
              <XRef ID="46627" DB="Orphanet" />
              <XRef ID="C1868570" DB="MedGen" />
              <XRef ID="MONDO:0008209" DB="MONDO" />
              <XRef Type="MIM" ID="169100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1688781" SubmissionDate="2018-12-19" DateLastUpdated="2018-12-24" DateCreated="2018-12-24">
        <ClinVarSubmissionID localKey="SUB4855160" submittedAssembly="GRCh37" title="SUB4855160" />
        <ClinVarAccession Accession="SCV000853288" DateUpdated="2018-12-24" DateCreated="2018-12-24" Type="SCV" Version="1" SubmitterName="Medical Genetics, American University of Beirut" OrgID="506809" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Char syndrome is caused by a genetic mutation in the transcription factor AP-2 Beta (TFAP2B) gene and follows an autosomal dominant mode of inheritance. Complete penetrance and variable expression have been reported. Various animal experimental studies showed that the TFAP2B gene product plays a critical role in the remodeling of the patent ductus arteriosus (PDA) as well as limb patterning. Most reported pathogenic variants in TFAP2B gene are missense mutations in the coding region, affecting the basic domain that is critical for DNA binding. Other reported mutations are intronic point mutations that alter splicing, or frameshift deletions. In this study we report a child with a novel heterozygous TFAP2B mutation c.650delG p.(Gly217Alafs*32), occurring de novo.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Ethnicity>Middle Eastern</Ethnicity>
              <GeographicOrigin>Iraq</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina platform</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <Description>RNA capture baits against approximately 60 Mb of the Human Exome (targeting &gt;99% of regions in CCDS, RefSeq and Gencode databases) is used to enrich regions of interest from fragmented genomic DNA with Agilentâ€™s SureSelect Human All Exon V6 kit. The generated library is sequenced on an Illumina platform to obtain an average coverage depth of ~100x. Typically, ~97% of the targeted bases are covered &gt;10x. An end to end in-house bioinformatics pipeline including base calling, alignment of reads to GRCh37/hg19 genome assembly, primary filtering out of low quality reads and probable artifacts, and subsequent annotation of variants, is applied. All disease causing variants reported in HGMDÂ®, in ClinVar or in CentoMDÂ® as well as all variants with minor allele frequency (MAF) of less than 1% in gnomAD database are considered. Evaluation is focused on coding exons along with flanking +/-20 intronic bases. All pertinent inheritance patterns are considered. In addition, provided family history and clinical information are used to evaluate eventually identified variants. All identified variants are evaluated with respect to their pathogenicity and causality, and these are categorized into classes 1 - 5. All variants related to the phenotype of the patient, except benign or likely benign variants, are reported. Variants of relevance identified by NGS are continuously and individually in-house validated for quality aspects; those variants which meet our internal QC criteria (based on extensive validation processes) are not validated by Sanger.</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome Sequencing- GTR000528706.2</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2018-11-14">CentoGene</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2017-01-12" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002553" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000337" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000455" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000369" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004209" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000322" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TFAP2B">
              <Name>transcription factor AP-2 beta</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_003221.3:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.(Gly217Alafs*32)</Name>
          </OtherNameList>
          <FunctionalConsequence Value="protein truncation">
            <XRef DB="Variation Ontology" ID="0015" URL="http://purl.obolibrary.org/obo/VariO_0015" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003221.3:c.650delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="169100" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4855160</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Disease" MappingType="XRef" MappingValue="169100" MappingRef="OMIM">
        <MedGen CUI="C1868570" Name="Char syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000455" MappingRef="HP">
        <MedGen CUI="C0426429" Name="Broad nasal tip" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000322" MappingRef="HP">
        <MedGen CUI="C1861324" Name="Short philtrum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004209" MappingRef="HP">
        <MedGen CUI="C1850049" Name="Clinodactyly of the 5th finger" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000337" MappingRef="HP">
        <MedGen CUI="C1849089" Name="Broad forehead" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002553" MappingRef="HP">
        <MedGen CUI="C1868571" Name="Highly arched eyebrow" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1688781" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000369" MappingRef="HP">
        <MedGen CUI="C0239234" Name="Low-set ears" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

